Delivery Order SPE2D024D0002-SPE2D325F303Y
Award Date 8/7/25
Potential Completion Date 8/8/25
Potential Value $4.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Mason, OH 45040, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S pharmaceutical tablets to the Medical Supply Chain, a defense agency. The $3,981.04 firm-fixed-price Delivery Order was awarded to Prasco, LLC, a pharmaceutical company based in Mason, Ohio. Prasco is an experienced federal contractor, holding several Indefinite Delivery Vehicle (IDV) contracts with the Department of Veterans Affairs (VA) for pharmaceutical and drug products, with a total ceiling value of over...
- Prasco, LLC was awarded a $24,647.04 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) to provide 250mg/100mg doses of atovaquone/proguanil hydrochloride for the Centers for Disease Control and Prevention (CDC). The order is for Product #3 under the schedule and must be completed by August 15, 2023. Performance will take place in Mason, Ohio. No set-aside provisions were applied to this award to supply anti-malarial drugs in support of the CDC's global...
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $24,647.04 delivery order to Prasco, LLC for atovaquone/proguanil tablets. The contract has a completion date of March 1, 2023 and was awarded on February 23, 2023 under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), a multiple award schedule with firm fixed pricing. Performance will take place in Mason, Ohio. No set-aside designation was used for this order to supply...
- The U.S. Medical Supply Chain awarded a $131,046.26 firm fixed-price delivery order to Prasco, LLC, a pharmaceutical company headquartered in Mason, Ohio, on June 4, 2024, with completion scheduled for June 5, 2025. This delivery order, which carries no set-aside designation, is issued under one of Prasco's larger Indefinite Delivery/Indefinite Quantity (IDIQ) contracts with the Medical Supply Chain valued at $31.7 billion through June 2034. Prasco specializes in manufacturing and distributing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Atovaquone-Proguanil 250-100 tablets in a quantity of 100 units, with a ceiling value of $1,343.16. This contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, and represents a non-competitive set-aside transaction. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- This is a $3,354.45 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a malaria treatment medication. The contract has a completion date of June 10, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,712 units of the anti-malarial drug combination Atovaquone-Proguanil 250-100 mg. The delivery order, valued at $6,806.00, was issued under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that has a ceiling value of up to $999,999,999 and runs through December 2025. This contract does not have a set-aside...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,565,912,417 units of Atovaquone-Proguanil 250-100mg tablets. The contract has a firm-fixed price of $4,079.80 and a completion date of September 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December...
- This is a $1,871.79 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a malaria treatment medication. The delivery order has a completion date of July 11, 2025 and is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp also holds a $999,999,999.00...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,958,212 units of Atovaquone-Proguanil 250-100 100S, a pharmaceutical product, with a ceiling value of $2,658.91. The contract has an ultimate completion date of April 18, 2025 and was awarded on April 17, 2025. This delivery order is part of a larger Indefinite Delivery...